BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
PDX1
,
Fatty acid metabolic process
,
Lung cancer
,
Hippocampus
,
Nosology
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
BCL w
Summary
General Info
Curated Studies
Most Correlated Studies
Surviving Sepsis: Bcl-2 Overexpression Modulates Splenocyte Transcriptional Responses
Differentially expressed genes during disuse atrophy of skeletal muscle
Skeletal muscle of weight bearing and non-weight bearing hind limbs of Nfkb1 KO, Bcl3 KO, or WT mice
Non-Hodgkin lymphoma Mino cells treated with ARV-771, ARV-825 or OTX015
Zebrafish fibroblasts at 6, 12, 24hr post infection with infectious pancreatic necrosis virus (IPNV)
Explore Curated Studies Results
Literature
Most Relevant Literature
Novel read-through fusion transcript Bcl2l2-Pabpn1 in glioblastoma cells.
PABPN1 loss-of-function causes APA-shift in oculopharyngeal muscular dystrophy.
PABPN1 functions as a predictive biomarker in colorectal carcinoma.
PABPN1 aggregation is driven by Ala expansion and poly(A)-RNA binding, leading to CFIm25 sequestrati…
Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate canc…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Use of Venetoclax as Single Agent in Patients With Relapsed/Refractory BCL-2 Positive Peripheral T C…
2157GCCC:Phase 1 of Calaspargase Pegol-mknl w/ Cytarabine and Idarubicin in Newly Dx AML
A Study of Pelcitoclax (APG-1252) in Patients With Neuroendocrine Tumors
APG-1252 in Patients With SCLC or Advanced Solid Tumors
A Study of APG-1252 in Patients With SCLC or Other Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ